Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Hannes A. Baukmann"'
Autor:
Hannes A. Baukmann, Justin L. Cope, Colin Bannard, Alexander R.E.C. Schwinges, Margaretha R.J. Lamparter, Sarah Groves, Charles N.J. Ravarani, Borko Amulic, Joern E. Klinger, Marco F. Schmidt
Publikováno v:
iScience, Vol 26, Iss 11, Pp 108185- (2023)
Summary: Despite recent development of vaccines to prevent SARS-CoV-2 infection, treatment of critically ill COVID-19 patients remains an important goal. In principle, genome-wide association studies (GWASs) provide a shortcut to the clinical evidenc
Externí odkaz:
https://doaj.org/article/c4de6486f93f4a66976a2df74b52e121
Autor:
Grit Zahn, Hannes A. Baukmann, Jasmine Wu, Jens Jordan, Andreas L. Birkenfeld, Naomi Dirckx, Marco F. Schmidt
Publikováno v:
Metabolites, Vol 13, Iss 12, p 1186 (2023)
Reduced expression of the plasma membrane citrate transporter SLC13A5, also known as INDY, has been linked to increased longevity and mitigated age-related cardiovascular and metabolic diseases. Citrate, a vital component of the tricarboxylic acid cy
Externí odkaz:
https://doaj.org/article/01fe8716f85649ccbdeaaf5fbe349067
Autor:
Justin L. Cope, Hannes A. Baukmann, Jörn E. Klinger, Charles N. J. Ravarani, Erwin P. Böttinger, Stefan Konigorski, Marco F. Schmidt
Publikováno v:
Frontiers in Genetics, Vol 12 (2021)
Polygenic risk scores (PRS) aggregating results from genome-wide association studies are the state of the art in the prediction of susceptibility to complex traits or diseases, yet their predictive performance is limited for various reasons, not leas
Externí odkaz:
https://doaj.org/article/a1e9ca0dff42441b8518aca4ba8307bf
Autor:
Marco F. Schmidt, Hannes A. Baukmann, Justin L. Cope, Charles N. J. Ravarani, Colin Bannard, Margaretha R. J. Lamparter, Alexander R. E. C. Schwinges, Joern E. Klinger
Despite the recent development of vaccines and monoclonal antibodies preventing SARS-CoV-2 infection, treating critically ill COVID-19 patients still remains a top goal. In principle, drug repurposing -- the use of an already existing drug for a new
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c986e2da72527634e756d3b10fce9a1
https://doi.org/10.21203/rs.3.rs-1469211/v1
https://doi.org/10.21203/rs.3.rs-1469211/v1
Autor:
Jörn Klinger, Marco F. Schmidt, Justin L. Cope, Erwin Boettinger, Hannes A. Baukmann, Stefan Konigorski, Charles N. J. Ravarani
Publikováno v:
Frontiers in Genetics
Frontiers in Genetics, Vol 12 (2021)
Frontiers in Genetics, Vol 12 (2021)
Polygenic risk scores (PRS) aggregating results from genome-wide association studies are the state of the art in the prediction of susceptibility to complex traits or diseases, yet their predictive performance is limited for various reasons, not leas
Autor:
Joern E. Klinger, Colin Bannard, Hannes A. Baukmann, Alexander R. E. C. Schwinges, Justin L. Cope, Marco F. Schmidt, Margaretha R. J. Lamparter, Charles N. J. Ravarani
Despite the recent development of vaccines and monoclonal antibodies preventing SARS-CoV-2 infection, treating critically ill COVID-19 patients still remains a top goal. In principle, drug repurposing – the use of an already existing drug for a new
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7c73281bd3f882d754b4bd3c0001d97
https://doi.org/10.21203/rs.3.rs-568366/v1
https://doi.org/10.21203/rs.3.rs-568366/v1
Autor:
Hannes A. Baukmann, Justin L. Cope, Charles N. J. Ravarani, Colin Bannard, Margaretha R. J. Lamparter, Alexander R. E. C. Schwinges, Joern E. Klinger, Marco F. Schmidt
BackgroundDespite recent development of vaccines and monoclonal antibodies to prevent SARS-CoV-2 infection, treatment of critically ill COVID-19 patients remains an important goal. In principle, genome-wide association studies (GWAS) could shortcut t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e782cd079d452538111b75dd367cf8d
https://doi.org/10.1101/2021.05.18.21256584
https://doi.org/10.1101/2021.05.18.21256584